Download PDF
Homeopathy 2014; 103(03): 165-171
DOI: 10.1016/j.homp.2014.03.002
Original Paper
Copyright © The Faculty of Homeopathy 2014

China rubra for side-effects of quinine: a prospective, randomised study in pregnant women with malaria in Cotonou, Benin

Karine Danno
1   Laboratoires Boiron, 20 rue de la Libération, Sainte-Foy-lès-Lyon, France
,
Frédéric Rerolle
2   Homéopathes Sans Frontières – France, 14 bis avenue Jacques Douzans, Muret, France
,
Sylvie de Sigalony
2   Homéopathes Sans Frontières – France, 14 bis avenue Jacques Douzans, Muret, France
,
Aurélie Colas
1   Laboratoires Boiron, 20 rue de la Libération, Sainte-Foy-lès-Lyon, France
,
Laurence Terzan
1   Laboratoires Boiron, 20 rue de la Libération, Sainte-Foy-lès-Lyon, France
,
Marie-France Bordet
1   Laboratoires Boiron, 20 rue de la Libération, Sainte-Foy-lès-Lyon, France
› Author Affiliations
Subject Editor:
Further Information

Publication History

Received16 July 2013
revised10 February 2014

accepted04 March 2014

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

Background: In endemic areas, gestational malaria is responsible for low birth weight and maternal anaemia. Quinine is the reference treatment for acute malaria in pregnant women, irrespective of term. However, quinine administration is associated with various side-effects. We evaluated the impact of the homeopathic medicine China rubra 7CH on the side-effects of quinine used as treatment for acute malaria in pregnant women in Cotonou, Benin.

Methods: This prospective, comparative, randomised study was carried out between June and December 2007 in the Saint Jean-Baptiste Medical Centre, Cotonou. Women were included if they were >3 months pregnant and had a clinical diagnosis of malaria confirmed by a positive thick blood smear. The study population was divided into two groups: (i) patients who presented between the 1st and 15th of each month and who received China rubra 7CH plus quinine (China group); and (ii) patients who presented from the 16th to the end of each month and who received treatment with quinine only (Standard group). The aim was to compare the frequency of side-effects of quinine in the two groups until day 6 after the start of treatment. Neither the patients nor the care givers were blinded to study treatment. Statistical comparison of the two groups was carried out with an alpha risk fixed at 5%.

Results: 211 women were recruited: 105 received quinine plus China rubra 7CH (China group) and 106 received quinine only (Standard group). A decrease in proportion of patients presenting with side-effects was observed in the China group from day 0 to day 6 of follow-up (53.9%–23.3%) whereas the proportion of patients with side-effects in the Standard group did not change significantly (85.9% on day 0 vs. 82.5% on day 6). Ninety-six (72.4%) patients in the China group and 103 (97.2%) in the Standard group reported at least one side-effect during follow-up (p < 0.0001). The most frequently reported side-effects were tinnitus, dizziness and asthenia.

Conclusions: This preliminary study shows the interest of China rubra 7CH in limiting the side-effects of quinine used for the treatment of acute malaria in pregnant women.

Keywords

Homeopathy - China rubra - Quinine - Side-effects - Malaria - Pregnancy
 

  • References

  • 1 Résumé du Rapport OMS 2011 sur le Paludisme. http://www.who.int/mediacentre/factsheets/fs094/fr March 2014.
    PubMed
  • 2 Chan A. Avant-propos Dr Margaret Chan: Directeur Général de l'Organisation mondiale de la Santé. http://www.who.int/malaria/world_malaria_report_2011/wmr2011_foreword_french.pdf 2011.
    PubMed
  • 3 Badarou S. Editorial du Docteur Soliou BADAROU: Lutte contre le paludisme au Bénin: point et perspectives. http://www.santetropicale.com/benin/bada0307.htm February 2008.
    PubMed
  • 4 Briand V., Bottero J., Noël H. et al Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis 2009; 200: 991-1001.
    CrossrefPubMedGoogle Scholar
  • 5 OMS. Le paludisme chez la femme enceinte. Lignes directrices pour la mesure des indicateurs clés utilisés aux fins du suivi et de l'évaluation. 2007. Organisation Mondiale de la Santé; http://www.who.int/malaria/docs/mip/mip_guidelines_fr.pdf.
    Google Scholar
  • 6 Ministèresanté. PNLP Benin. République du Bénin. Ministère de la Santé. Direction Nationale de la Protection Sanitaire. Programme National de Lutte contre le Paludisme. Plan stratégique de lutte contre le paludisme au Bénin 2006 – 2010. 2007. Décembre http://www.rbm.who.int/countryaction/nsp/benin.pdf.
    Google Scholar
  • 7 Ogetii G.N., Akech S., Jemutai J. et al Hypoglycaemia in severe malaria, clinical associations and relationship to quinine dosage. BMC Infect Dis 2010; 10: 334.
    CrossrefPubMedGoogle Scholar
  • 8 Flanagan K.L., Buckley-Sharp M., Doherty T., Whitty C.J. Quinine levels revisited: the value of routine drug level monitoring for those on parenteral therapy. Acta Trop 2006; 97: 233-237.
    CrossrefPubMedGoogle Scholar
  • 9 Padmaja U.K., Adhikari P., Periera P. Experience with quinine in falciparum malaria. Indian J Med Sci 1999; 53: 153-157.
    PubMedGoogle Scholar
  • 10 Tumwikirize W.A., Ogwal-Okeng J.W., Vernby A., Anokbonggo W.W., Gustafsson L.L., Lundborg S.C. Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci 2011; 11: 72-78.
    PubMedGoogle Scholar
  • 11 Tariq M., Saleem T., Ullah H. et al Efficacy and safety of quinine loading dose in patients with severe falciparum malaria at a tertiary care hospital in Pakistan. J Pak Med Assoc 2011; 61: 27-31.
    PubMedGoogle Scholar
  • 12 Verdier M.C., Bentue-Ferrer D., Tribut O. Therapeutic drug monitoring of quinine. Therapie 2011; 66: 507-516.
    CrossrefPubMedGoogle Scholar
  • 13 Sowunmi A., Salako L.A. Effect of dose size on the pharmacokinetics of orally administered quinine. Eur J Clin Pharmacol 1996; 49: 383-386.
    CrossrefPubMedGoogle Scholar
  • 14 Guermonprez M., Pinkas M., Torck M. Matière Médicale Homéopathique. 3rd edn. 2005. Boiron; 141.
    Google Scholar
  • 15 Zissu R., Guillaume M. Fiches de Matière Médicale Homéopathique. 2005. Boiron; 173.
    Google Scholar
  • 16 Rabanes O. Hahnemann et la recherche de similitude: étude des sources contemporaines. Cahiers Group Hahnemann 2001; 38: 161-171.
    PubMedGoogle Scholar
  • 17 Kassab S., Cummings M., Berkovitz S., van Haselen R., Fisher P. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2009; 15: CD004845.
    PubMedGoogle Scholar
  • 18 Oberbaum M., Yaniv I., Ben-Gal Y. et al A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001; 92: 684-690.
    CrossrefPubMedGoogle Scholar
  • 19 Schneider B., Klein P., Weiser M. Treatment of vertigo with a homeopathic complex remedy compared with usual treatments: a meta-analysis of clinical trials. Arzneimittelforschung 2005; 55: 23-29.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Issing W., Klein P., Weiser M. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial. J Altern Complement Med 2005; 11: 155-160.
    CrossrefPubMedGoogle Scholar
  • 21 Weiser M., Strösser W., Klein P. Homeopathic vs. conventional treatment of vertigo: a randomized double-blind controlled clinical study. Arch Otolaryngol Head Neck Surg 1998; 124: 879-885.
    CrossrefPubMedGoogle Scholar
  • 22 Crompton R. Homeopathy for common complaints during pregnancy and childbirth. Pract Midwife 2012; 15: S15-S18.
    PubMedGoogle Scholar
  • 23 Goldstein B., Shulman A., Avitable M.J. Clear Tinnitus, middle-ear pressure, and tinnitus relief: a prospective trial. Int Tinnitus J 2007; 13: 29-39.
    PubMedGoogle Scholar
  • 24 Boericke W. Homoeopathic materia medica, 9th edn, Médi-T. http://www.homeoint.org/books/boericmm/index.htm 2000.
    PubMed
  • 25 Nguta J.M., Mbaria J.M., Gakuya D.W., Gathumbi P.K., Kiama S.G. Antimalarial herbal remedies of Msambweni, Kenya. J Ethnopharmacol 2010; 128: 424-432.
    CrossrefPubMedGoogle Scholar
  • 26 Muthaura C.N., Rukunga G.M., Chhabra S.C., Mungai G.M., Njagi E.N. Traditional antimalarial phytotherapy remedies used by the Kwale community of the Kenyan Coast. J Ethnopharmacol 2007; 114: 377-386.
    CrossrefPubMedGoogle Scholar
  • 27 Asase A., Akwetey G.A., Achel D.G. Ethnopharmacological use of herbal remedies for the treatment of malaria in the Dangme West District of Ghana. J Ethnopharmacol 2010; 129: 367-376.
    CrossrefPubMedGoogle Scholar
  • 28 Moshi M.J., Otieno D.F., Weisheit A. Ethnomedicine of the Kagera Region, north western Tanzania. Part 3: plants used in traditional medicine in Kikuku village, Muleba District. J Ethnobiol Ethnomed 2012; 8: 14.
    CrossrefPubMedGoogle Scholar